Launch week offerEnds in00h00m00s

Christoph Rademacher profile picture

Christoph Rademacher

Has grant

Professor for Molecular Drug Targeting

Universität Wien
Country flagAustria

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Modulation of platelet biology with CLEC-2 targeted liposomes

Open Date: 2022-06-01

Close Date: 2025-11-30

Grant: Close

Ligand-based targeted delivery for murine Langerin

Open Date: 2021-06-01

Close Date: 2024-05-31

Grant: Close

Immunotherapy of cancer with Langerin-ligand liposomes

Open Date: 2020-12-01

Close Date: 2024-11-30

Grant: Close

Design of ligand-based targeted delivery vehicles for the murine C-type lectin receptor Langerin

Open Date: 2020-01-01

Close Date:

Grant: Close

Emergent properties of cell surface glycosylation in cell-cell communication

Open Date: 2017-02-01

Close Date: 2023-09-30

Positions (1)

Publisher
source

Christoph Rademacher

University Name
.

University of Vienna

The Molecular Drug Targeting (MDT) lab at the University of Vienna, led by Professor Christoph Rademacher, is seeking a postdoctoral researcher with expertise in synthetic organic chemistry, medicinal chemistry, or chemical biology. The position is based in the Department of Pharmaceutical Sciences, offering an excellent environment for advanced research in drug targeting and pharmaceutical innovation. The MDT lab focuses on cutting-edge research at the intersection of chemistry and biology, aiming to develop novel strategies for drug delivery and molecular targeting. Applicants should hold a PhD in a relevant field and demonstrate a strong background in synthetic organic or medicinal chemistry, or chemical biology. The successful candidate will join a vibrant research community at the University of Vienna and have access to state-of-the-art facilities. The position is ideal for researchers interested in advancing their careers in pharmaceutical sciences and contributing to impactful research in drug targeting. The application deadline is January 31, 2026. Interested candidates should apply via the official university portal. For more information about the MDT lab and Professor Rademacher, please refer to the provided LinkedIn profile and university resources. Key research areas include molecular drug targeting, synthetic organic chemistry, medicinal chemistry, and chemical biology. The University of Vienna is a leading institution in pharmaceutical sciences, providing a supportive environment for postdoctoral researchers. Funding details are not specified, but the position is a standard postdoctoral university assistant role.

10 months ago

Articles (18)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Péter Ábrányi-Balogh

Budapest University of Technology and Economics

HUNGARY
View details

Dennis Kurzbach

Universität Wien

AUSTRIA
View details

Petra Ménová

University of Chemistry and Technology

CZECH REPUBLIC
View details

Mads Hartvig Clausen

Technical University of Denmark

DENMARK
View details

Anne Imberty

Senior researcher

Université Grenoble Alpes

FRANCE
View details

Gitta Schlosser

Eötvös Loránd University

HUNGARY
View details

Alexander Titz

Professor of Organic and Pharmaceutical Chemistry

Saarland University

GERMANY
View details

Bernhard Loll

Principial Investigator

Freie Universität Berlin

GERMANY
View details

LITTY JOHNSON

University of Birmingham

UNITED KINGDOM
View details

Maurice Besch

Prae Doc

Universität Wien

AUSTRIA
View details

Adelheid Elbe-Bürger

Lab head

Medical University of Vienna

AUSTRIA
View details